Intracerebral Hemorrhage News and Research

RSS

Intracerebral hemorrhage (ICH) is sudden, catastrophic bleeding that occurs in the brain tissue or ventricles. It usually results from damage to blood vessels due to hypertension. Symptoms are often sudden and severe. Loss of consciousness, vomiting, and headache are all common, but milder presentations are also possible, resembling ischemic stroke.

Imaging-based therapy benefits ‘wake-up stroke’ patients

Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.

5 Nov 2012

Imaging-based therapy benefits ‘wake-up stroke’ patients

Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.

26 Oct 2012

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Research shows that use of popular antidepressants is linked to an increased risk of some strokes caused by bleeding in the brain, but that the risk is low, according to a multi-study analysis published in the October 17, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2012

SSRI use linked to brain hemorrhage

Use of selective serotonin reuptake inhibitors is associated with an increased risk for brain hemorrhage, particularly intracerebral bleeding, suggest meta-analysis findings.

18 Oct 2012

Visual clue to ICH outcomes

Persistent conjugate eye deviation predicts poor outcomes in patients with intracerebral hemorrhage, say researchers.

19 Sep 2012

Heavy drinking risks early severe stroke

Heavy alcohol drinkers are at high risk for suffering intracerebral hemorrhage at a relatively young age, say researchers.

14 Sep 2012

Research examines racial and ethnic differences in strokes

Blacks who survived a stroke caused by bleeding in the brain had higher blood pressure than whites a year later, according to a study published today in the journal Stroke. The finding might help explain why blacks have a greater risk of suffering a second stroke than whites.

17 Aug 2012

Ischemic lesions signal preventive needs in ICH patients

The finding of new ischemic lesions in patients with hypertensive intracerebral hemorrhage identifies patients at the greatest need of preventive therapy, research published in Neurology suggests.

8 Aug 2012

Lipid treatment absolved of hemorrhagic transformation guilt

The lipid profiles of patients undergoing thrombolysis for acute stroke predict their mortality risk but not their risk for symptomatic intracerebral hemorrhage, shows a large study.

1 Aug 2012

‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

27 Jun 2012

‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

27 Jun 2012

Intensive insulin may backfire in acute stroke

Intensive control of glucose levels in patients with hyperacute stroke may do more harm than good, results of the randomized INSULINFARCT trial suggest.

25 Jun 2012

Aspirin versus warfarin for heart failure patients

In a new study on more than 2,000 patients, published in the New England Journal of Medicine, researchers found that aspirin was as effective as the commonly prescribed drug warfarin. It said each drug had risks, but they had similar benefits overall.

4 May 2012

Results from Merck's vorapaxar study on cardiovascular events

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

26 Mar 2012

Medidata names EXTEDO as technology partner

Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.

19 Mar 2012

Study: Thrombolytic therapy can be safely used in children with stroke

New research looks at whether clot-busting drugs can safely be given to children who have strokes. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.

18 Feb 2012

Top-line results from Merck's vorapaxar clinical study on thrombosis

Merck, known outside the United States and Canada as MSD, today announced the top-line results of the TRA-2P (Thrombin Receptor Antagonist in Secondary Prevention of atherothrombotic ischemic events) study of vorapaxar.

7 Feb 2012

CT-guided catheters carry t-PA to shrink clots in patients with ICH

Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months following the procedure.

4 Feb 2012

Aspirin and warfarin similar in preventing deaths and strokes in heart failure patients

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.

4 Feb 2012